Table 2

Time to first occurrence of MACE,adjusted for baseline HGI tertile and HbA1c in the whole trial population

MACE HR (95% CI)
HGI
Low vs moderate1.15 (0.92 to 1.44)
High vs moderate1.22 (0.98 to 1.53)
P value for interaction between HGI tertile and outcome0.1598
HbA1c
≥9% vs ≥7.5−<9%1.42 (1.15 to 1.76)
<7.5% vs ≥7.5–<9%0.99 (0.79 to 1.24)
P value for interaction between HGI tertile and outcome0.0046
  • HbA1c, glycated hemoglobin; HGI, hemoglobin glycation index; MACE, major adverse cardiovascular event.